logo.png
Regenerative Medicine Market Size Expected to Reach USD 154.05 Bn by 2033
April 26, 2024 11:10 ET | Precedence Research
Ottawa, April 26, 2024 (GLOBE NEWSWIRE) -- According to Precedence Research, the global regenerative medicine market size is calculated at USD 35.82 billion in 2024. Regenerative medicines are used...
Longeveron Logo.jpg
Longeveron to Present at the Planet MicroCap Showcase
April 25, 2024 16:05 ET | Longeveron
Longeveron to present at investor conference - Planet MicroCap Showcase - May 1, 2024.
22157.jpg
Cell Cryopreservation - Global Market Analysis to 2030 Featuring Profiles of Merck, Thermo Fisher Scientific, Sartorius, PromoCell, and Lonza Group
April 25, 2024 10:28 ET | Research and Markets
Dublin, April 25, 2024 (GLOBE NEWSWIRE) -- The "Global Cell Cryopreservation Market Size, Share & Industry Trends Analysis, 2023-2030" report has been added to ResearchAndMarkets.com's...
Global Cell Expansion Market
Global Cell Expansion Market Landscape 2024-2029 Featuring Analysis of Thermo Fisher Scientific, Danaher Corp, Merck, Sartorius, Corning, and More
April 19, 2024 04:05 ET | Research and Markets
Dublin, April 19, 2024 (GLOBE NEWSWIRE) -- The "Global Cell Expansion Market Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.The global cell expansion market is...
Longeveron Logo.jpg
Longeveron Announces Exercise of Warrants for $6.2 Million Gross Proceeds
April 17, 2024 08:00 ET | Longeveron
Longeveron raises gross proceeds of ~$6.2 M from exercise of certain existing warrants to purchase an aggregate of 2,399,744 shares of its common stock.
Longeveron Logo.jpg
Longeveron Announces Closing of $5.2 Million Public Offering
April 11, 2024 17:17 ET | Longeveron
Longeveron announces closing of previously announced public offering, raising $5.25 million in gross proceeds.
22157.jpg
3D Cell Culture Report 2024: 3D Bioprinting Holds Potential to Revolutionize Organ Transplantation Space
April 08, 2024 08:53 ET | Research and Markets
Dublin, April 08, 2024 (GLOBE NEWSWIRE) -- The "3D Cell Culture - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for 3D Cell Culture...
Longeveron Logo.jpg
Longeveron Issues Letter to Shareholders Highlighting Corporate Strategy, Clinical Pipeline and 2024 Key Priorities and Goals
April 08, 2024 08:30 ET | Longeveron
CEO Letter to Shareholders. Update on overall strategy, business objectives, approach to capital allocation, and 2024 key priorities and goals.
22157.jpg
Life Science Tools Global Strategic Research Report 2024: Market to Reach $258.6 Billion by 2030 - Connected Devices, IoT Ecosystems to Transform the Life Science Landscape
April 05, 2024 09:19 ET | Research and Markets
Dublin, April 05, 2024 (GLOBE NEWSWIRE) -- The "Life Science Tools - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Life Science Tools Market to...
Global Regenerative Medicine Market
Global Regenerative Medicine Industry Research 2023-2028: Market Driven by Wide Scope in New Therapeutic Areas and Collaborations and Partnerships
April 03, 2024 09:43 ET | Research and Markets
Dublin, April 03, 2024 (GLOBE NEWSWIRE) -- The "Global Regenerative Medicine Market by Product (Stem Cell [Autologous, Allogenic], Immunotherapy, Gene Therapy, Tissue Engineering), Application...